Constitutive NF-kB Activity in Neurons

REFERENCES

• Bachelerie, F., J. Alcami, S. F. Arenzana, and J. L. Virelizier. 1991. HIV enhancer activity perpetuated by NF-kB induction on infection of monocytes. Nature (London) 350: 709–712.
   PubMed Web of Science ®Google Scholar
• Baeuerle, P. A. 1991. The inducible transcription activator NF-kB: regulation by distinct protein subunits. Biochim. Biophys. Acta 1072: 63–80.
   PubMed Web of Science ®Google Scholar
• Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-kB in the immune system. Annu. Rev. Immunol. 12: 147–179.
   Google Scholar
• Baeuerle, P. A., M. Lenardo, J. W. Pierce, and D. Baltimore. 1988. Phorbol-ester-induced activation of the NF-kB transcription factor involves dissociation of an apparently cytoplasmic NF-kB/ inhibitor complex. Cold Spring Harb. Symp. Quant. Biol. 2: 789–798.
   Google Scholar
• Banker, G., and K. Goslin. 1991. Culturing nerve cells, p. 251–307. MIT Press, Cambridge, Mass.
   Google Scholar
• Beg, A. A., T. S. Finco, P. V. Nantermet, and A. S. Baldwin, Jr. 1993. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IkB-α: a mechanism for NF-kB activation. Mol. Cell. Biol. 13: 3301–3310.
   PubMed Web of Science ®Google Scholar
• Beg, A. A., S. M. Ruben, R. I. Scheinman, S. Haskill, C. A. Rosen, and A. J. Baldwin. 1992. IkB interacts with the nuclear localization sequences of the subunits of NF-kB: a mechanism for cytoplasmic retention. Genes Dev. 6: 1899–1913.
   PubMed Web of Science ®Google Scholar
• Blank, V., P. Kourilsky, and A. Israel. 1992. NF-kB and related proteins: Rel/dorsal homologies meet ankyrin-like repeats. Trends Biochem. Sci. 17: 135–140.
   PubMed Web of Science ®Google Scholar
• Bours, V., G. Franzoso, V. Azarenko, S. Park, T. Kanno, K. Brown, and U. Siebenlist. 1993. The oncoprotein Bcl-3 directly transacti-vates through kB motifs via association with DNA-binding p50B homodimers. Cell 72: 729–739.
   PubMed Web of Science ®Google Scholar
• Brew, B. J. 1993. HIV-l-related neurological disease. J. Acquired Immune Defic. Syndr. 6: (Suppl. 1): 10–15.
   PubMedGoogle Scholar
• Brown, K., S. Park, T. Kanno, G. Franzoso, and U. Siebenlist. 1993. Mutual regulation of the transcriptional activator NF-kB and its inhibitor IkB-α. Proc. Natl. Acad. Sci. USA 90: 2532–2536.
   PubMed Web of Science ®Google Scholar
• Burke, P. A., S. Hirschfeld, Y. Shirayoshi, J. W. Kasik, K. Hamada, E. Appella, and K. Ozato. 1989. Development and tissue-specific expression of nuclear proteins that bind the regulatory element of the major histocompatibility complex class I gene. J. Exp. Med. 169: 1309–1321.
   PubMedGoogle Scholar
• Corboy, J. R., J. M. Buzy, M. C. Zink, and J. E. Clements. 1992. Expression directed from HIV long terminal repeats in the central nervous system of transgenic mice. Science 258: 1804–1807.
   PubMed Web of Science ®Google Scholar
• De Wet, J. R., K. V. Wood, M. De Luca, D. R. Helinski, and S. Subramani. 1987. Firefly luciferase gene: structure and expression in mammalian cells. Mol. Cell. Biol. 7: 725–737.
   PubMed Web of Science ®Google Scholar
• Dickson, D. W., S. C. Lee, L. A. Mattiace, S. H. Yen, and C. Brosnan. 1993. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7: 75–83.
   PubMed Web of Science ®Google Scholar
• Dignam, J. P., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA in a soluble extract from mammalian nuclei. Nucleic Acids Res. 11: 1475–1489.
   PubMed Web of Science ®Google Scholar
• Franzoso, G., V. Bours, S. Park, Y. M. Tomita, K. Kelly, and U. Siebenlist. 1992. The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kb-mediated inhibition. Nature (London) 359: 339–342.
   PubMedGoogle Scholar
• Ganchi, P. A., S.-C. Sun, W. C. Greene, and D. W. Ballard. 1992. IkB/MAD-3 masks the nuclear localization signal of NF-kB p65 and requires the transactivation domain to inhibit NF-kB p65 DNA binding. Mol. Cell. Biol. 3: 1339–1352.
   Google Scholar
• Ghosh, S., and D. Baltimore. 1990. Activation in vitro of NF-kB by phosphorylation of its inhibitor IkB. Nature (London) 344: 678–682.
   PubMed Web of Science ®Google Scholar
• Griffin, G. E., K. Leung, T. M. Folks, S. Kunkel, and G. J. Nabel. 1989. Activation of HIV gene expression during monocyte differentiation by induction of NF-kB. Nature (London) 339: 70–73.
   PubMed Web of Science ®Google Scholar
• Grilli, M., J. J.-S. Chiu, and M. J. Lenardo. 1993. NF-kB and rel—participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143: 1–62.
   PubMed Web of Science ®Google Scholar
• Grimm, S., and P. Baeuerle. Submitted for publication.
   Google Scholar
• Harouse, J. M., S. Bhat, S. L. Spitalnik, M. Laughlin, K. Stefano, D. H. Silberberg, and S. F. Gonzalez. 1991. Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceram-ide. Science 253: 320–323.
   PubMed Web of Science ®Google Scholar
• Haskill, S., A. A. Beg, S. M. Tompkins, J. S. Morris, A. D. Yurochko, J. A. Sampson, K. Mondal, P. Ralph, and A. J. Baldwin. 1991. Characterization of an immediate-early gene induced in adherent monocytes that encodes IKB-like activity. Cell 65: 1281–1289.
   PubMed Web of Science ®Google Scholar
• Hatada, E. N., A. Nieters, F. G. Wulczyn, M. Naumann, R. Meyer, G. Nucifora, T. W. McKeithan, and C. Scheidereit. 1992. The ankyrin repeat domains of the NF-kB precursor pl05 and the protooncogene bcl-3 act as specific inhibitors of NF-kB DNA binding. Proc. Natl. Acad. Sci. USA 89: 2489–2493.
   PubMedGoogle Scholar
• Hemar, A., S. Cereghini, V. Cornet, V. Blank, A. Israel, W. C. Greene, and V. A. Dautry. 1991. kb-binding proteins are constitutively expressed in an IL-2 autocrine human T cell line. J. Immunol. 146: 2409–2416.
   PubMedGoogle Scholar
• Henkel, T., T. Machleidt, I. Alkalay, Y. Ben-Neriah, K. M. Kronke, and P. A. Baeuerle. 1993. Rapid proteolytic degradation of IkB-α is necessary for activation of transcription factor NF-kB. Nature (London) 365: 182–184.
   PubMed Web of Science ®Google Scholar
• Henkel, T., U. Zabel, Z. K. Van, J. M. Muller, E. Fanning, and P. A. Baeuerle. 1992. Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-kB subunit. Cell 68: 1121–1133.
   PubMed Web of Science ®Google Scholar
• Israel, N., M. A. Gougertot-Pocidalo, F. Aillet, and J. L. Virelizier. 1992. Redox status of cells influences constitutive or induced NF-kB translocation and HIV long terminal repeat activity in human T and monocytic cell lines. J. Immunol. 149: 3386–3393.
   PubMed Web of Science ®Google Scholar
• Kaltschmidt, C., B. Kaltschmidt, and P. A. Baeuerle. 1993. Brain synapses contain inducible forms of the transcription factor NF-kB. Mech. Dev. 43: 135–147.
   PubMedGoogle Scholar
• Kerr, L. D., J. Inoue, N. Davis, E. Link, P. A. Baeuerle, H. J. Bose, and I. M. Verma. 1991. The rel-associated pp40 protein prevents DNA binding of Rel and NF-kB: relationship with IkB beta and regulation by phosphorylation. Genes Dev. 5: 1464–1476.
   PubMedGoogle Scholar
• Korner, M., A. Rattner, F. Mauxion, R. Sen, and Y. Citri. 1989. A brain-specific transcription activator. Neuron 3: 563–572.
   PubMedGoogle Scholar
• Korner, M., N. Tarantino, and P. Debre. 1991. Constitutive activation of NF-kB in human thymocytes. Biochem. Biophys. Res. Commun. 181: 80–86.
   PubMedGoogle Scholar
• Masliah, E., C. L. Achim, N. Ge, R. DeTeresa, R. D. Terry, and C. A. Wiley. 1992. Spectrum of human immunodeficiency virus-associated neocortical damage. Ann. Neurol. 32: 321–329.
   PubMed Web of Science ®Google Scholar
• Moynagh, P. N., D. C. Williams, and L. A. J. O'Neill. 1993. Interleukin-1 activates transcription factor NFkB in glial cells. Biochem. J. 294: 343–347.
   Google Scholar
• Nabel, G. J., and D. Baltimore. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature (London) 326: 711–713.
   PubMed Web of Science ®Google Scholar
• Naumann, M., F. G. Wulczyn, and C. Scheidereit. 1993. The NF-kB precursor pl05 and the proto-oncogene product Bcl-3 are IkB molecules and control nuclear translocation of NF-kB. EMBO J. 12: 213–222.
   PubMedGoogle Scholar
• Nelsen, B., L. Hellmann, and R. Sen. 1988. The NF-kB binding site mediates phorbol ester-inducible transcription in nonlymphoid cells. Mol. Cell. Biol. 8: 3526–3531.
   PubMedGoogle Scholar
• Nolan, G. P., T. Fujita, K. Bhatia, K. Huppi, H.-C. Liou, M. L. Scott, and D. Baltimore. 1993. The bcl-3 proto-oncogene encodes a nuclear ikb-like molecule that preferentially interacts with NF-kB p50 in a phosphorylation-dependent manner. Mol. Cell. Biol. 13: 3557–3566.
   PubMedGoogle Scholar
• Rattner, A., M. Korner, M. D. Walker, and Y. Citri. 1993. NF-kB activates the HIV promoter in neurons. EMBO J. 12: 4261–4267.
   PubMed Web of Science ®Google Scholar
• Schreck, R., K. Albermann, and P. A. Baeuerle. 1992. Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic. Res. Commun. 17: 221–237.
   PubMed Web of Science ®Google Scholar
• Schreck, R., P. Rieber, and P. A. Baeuerle. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kB transcription factor and HIV-1. EMBO J. 10: 2247–2258.
   PubMed Web of Science ®Google Scholar
• Sen, R., and D. Baltimore. 1986. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46: 705–716.
   PubMed Web of Science ®Google Scholar
• Sen, R., and D. Baltimore. 1986. Inducibility of k immunoglobulin enhancer-binding protein NF-kB by a post-translational mechanism. Cell 47: 921–928.
   PubMed Web of Science ®Google Scholar
• Sun, S. C., P. A. Ganchi, D. W. Ballard, and W. C. Greene. 1993. NF-kB controls expression of inhibitor IkB-α: evidence for an inducible autoregulatory pathway. Science 259: 1912–1915.
   PubMed Web of Science ®Google Scholar
• Ten, R. M., C. V. Paya, N. Israel, O. Le Bail, M. G. Mattei, J. L. Virelizier, P. Kourilsky, and A. Israel. 1992. The characterization of the promoter of the gene encoding the p50 subunit of NF-kappa B indicates that it participates in its own regulation. EMBO J. 11: 195–203.
   PubMed Web of Science ®Google Scholar
• Thompson, R. J. 1987. Isolation of mammalian brain cell nuclei, p. 225–242. In A. J. Turner, and H. S. Bachelard (ed.), Neurochem-istry. IRL Press, Oxford.
   Google Scholar
• Wigler, M., R. Sweet, G. Sim, A. Pellicer, V. Lacy, T. Maniatis, S. Silverstein, and R. Axel. 1979. Transformation of mammalian cells with genes from prokaryotes and eukaryotes. Cell 16: 777–785.
   PubMed Web of Science ®Google Scholar
• Wulczyn, F. G., M. Naumann, and C. Scheidereit. 1992. Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-kB. Nature (London) 358: 597–599.
   PubMedGoogle Scholar
• Zabel, U., and P. A. Baeuerle. 1990. Purified human IkB can rapidly dissociate the complex of the NF-kB transcription factor with its cognate DNA. Cell 61: 255–265.
   PubMed Web of Science ®Google Scholar
• Zabel, U., T. Henkel, M. S. Silva, and P. A. Baeuerle. 1993. Nuclear uptake control of NF-kB by MAD-3, an IkB protein present in the nucleus. EMBO J. 12: 201–211.
   PubMedGoogle Scholar